Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of HPV-16/18 VLP Vaccine in Healthy Young Women
NCT00689741Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2001
- Primary completion
- Apr 2003
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen in human papillomavirus infection, sponsored by GSK. Started Jan 2001; status: completed.
02
Drugs
Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00689741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689741.